VBIV - VBI Vaccines Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue8655489552,868
Cost of Revenue5,1933,6713,7533,699
Gross Profit-4,328-3,123-2,798-831
Operating Expenses
Research Development20,9189,96614,123634
Selling General and Administrative12,03411,7616,8382,728
Non Recurring----
Others----
Total Operating Expenses38,14525,39824,7147,061
Operating Income or Loss-37,280-24,850-23,759-4,193
Income from Continuing Operations
Total Other Income/Expenses Net-2,146-135-2,563-2,598
Earnings Before Interest and Taxes-37,280-24,850-23,759-4,193
Interest Expense-2,882-392-1,105-941
Income Before Tax-39,426-24,985-26,322-6,791
Income Tax Expense-431-1,780-129-1,119
Minority Interest----
Net Income From Continuing Ops-38,995-23,205-26,193-5,672
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-38,995-23,205-26,193-5,672
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-38,995-23,205-26,193-5,672